You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Moodys
Express Scripts
Johnson and Johnson
AstraZeneca

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Erythromycin Ethylsuccinate, and when can generic versions of Erythromycin Ethylsuccinate launch?

Erythromycin Ethylsuccinate is a drug marketed by Amneal Pharms, Ani Pharms Inc, Par Pharm Inc, Alpharma Us Pharms, Dista, Naska, Parke Davis, Pharmafair, Arbor Pharms Llc, Barr, and Mylan. and is included in thirteen NDAs.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.

Summary for ERYTHROMYCIN ETHYLSUCCINATE
Drug patent expirations by year for ERYTHROMYCIN ETHYLSUCCINATE
Pharmacology for ERYTHROMYCIN ETHYLSUCCINATE
Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN ETHYLSUCCINATE

US Patents and Regulatory Information for ERYTHROMYCIN ETHYLSUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate GRANULE;ORAL 211204-001 Nov 1, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Barr ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate TABLET;ORAL 062256-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm Inc ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate GRANULE;ORAL 211991-002 Oct 23, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate GRANULE;ORAL 062055-003 Nov 2, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Colorcon
Harvard Business School
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.